Advertisement
Screener

Alkermes plc. (ALKS) Pre-Tax Margin

Alkermes plc. (ALKS) Pre-Tax Margin

  • 2026-06-30: Pre-Tax Margin -0.38%.
  • 2026-03-31: Pre-Tax Margin -15.76%.
  • 2025-12-31: Pre-Tax Margin 15.70%.
  • 2025-09-30: Pre-Tax Margin 25.56%.

Complete source-backed pre-tax margin history.

Available history
2010-03-31 to 2026-06-30
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2026-06-30-0.38%
2026-03-31-15.76%
2025-12-3115.70%
2025-09-3025.56%
2025-06-3026.84%
2025-03-318.32%
2024-12-3139.51%
2024-09-3029.15%
2024-06-3029.24%
2024-03-3113.39%
2023-12-3115.45%
2023-09-3024.34%
2023-06-3045.65%
2023-03-31-3.94%
2022-12-3137.58%
2022-09-30-26.70%
2022-06-30-12.04%
2022-03-31-16.15%
2021-12-3139.22%
2021-09-30-9.02%
2021-06-301.86%
2021-03-31-7.42%
2020-12-31-14.87%
2020-09-300.83%
2020-06-30-10.41%
2020-03-31-12.72%
2019-12-31-0.62%
2019-09-30-21.10%
2019-06-30-14.43%
2019-03-31-44.94%
2018-12-31-0.54%
2018-09-30-13.60%
2018-06-30-8.02%
2018-03-31-29.76%
2017-12-313.92%
2017-09-30-16.46%
2017-06-30-20.87%
2017-03-31-37.85%
2016-12-31-11.39%
2016-09-30-36.25%
2016-06-30-24.45%
2016-03-31-49.13%
2015-12-31-44.63%
2015-09-30-51.11%
2015-06-30-28.44%
2015-03-31-18.70%
2014-12-3123.28%
2014-09-30-22.77%
2014-06-301.44%
2014-03-31-15.81%
2013-12-311.86%
2013-09-30-5.39%
2013-06-307.25%
2013-03-314.81%
2012-12-3115.20%
2012-09-30-13.14%
2012-06-3015.24%
2012-03-31-51.94%
2011-12-31-11.72%
2011-09-30-25.85%
2011-06-30-21.48%
2011-03-31-25.56%
2010-12-31-25.79%
2010-09-30-17.48%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-12-3119.75%
2024-12-3128.49%
2023-12-3125.34%
2022-12-31-2.80%
2021-12-317.47%
2020-12-31-9.29%
2019-12-31-16.83%
2018-12-31-11.60%
2017-12-31-15.86%
2016-12-31-28.75%
2015-12-31-35.65%
2014-12-31-2.27%
2013-12-312.22%
2013-03-316.16%
2012-03-31-29.33%
2011-03-31-24.91%
2010-03-31-25.07%

Similar stocks

Stock NameCountryMarket CapPE Ratio
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76